These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 186197)

  • 21. Effector mechanisms of cell-mediated immunity to xenogeneic cell antigens.
    Dennert G
    J Immunol; 1974 Jul; 113(1):201-8. PubMed ID: 4208918
    [No Abstract]   [Full Text] [Related]  

  • 22. Absence of enhancing antibody in cell mediated immunity to tumour heterografts in protein deficient rats.
    Jose DG; Good RA
    Nature; 1971 Jun; 231(5301):323-5. PubMed ID: 4996061
    [No Abstract]   [Full Text] [Related]  

  • 23. Inhibition of hepatoma-immune lymph-node cell cytotoxicity by tumour-bearer serum, and solubilized hepatoma antigen.
    Baldwin RW; Price MR; Robins RA
    Int J Cancer; 1973 May; 11(3):527-35. PubMed ID: 4364717
    [No Abstract]   [Full Text] [Related]  

  • 24. Tumour-specific antibody neutralization of factors in rat hepatoma-bearer serum which abrogate lymph-node-cell cytotoxicity.
    Robins RA; Baldwin RW
    Int J Cancer; 1974 Nov; 14(5):589-97. PubMed ID: 4376528
    [No Abstract]   [Full Text] [Related]  

  • 25. The effect of antibodies to complement components C2, C3 and C5 on the production and action of lymphotoxin.
    Gately MK; Mayer MM
    J Immunol; 1972 Oct; 109(4):728-34. PubMed ID: 5074329
    [No Abstract]   [Full Text] [Related]  

  • 26. Immunochemical detection of tumor-specific and embryonic antigens of diethylnitrosamine-induced guinea pig tumors.
    Borsos T; Richardson AK; Ohanian SH; Leonard EJ
    J Natl Cancer Inst; 1973 Dec; 51(6):1955-60. PubMed ID: 4128823
    [No Abstract]   [Full Text] [Related]  

  • 27. Studies on a gross-virus-induced lymphoma in the rat. I. The cell-mediated immune response.
    Shellam GR
    Int J Cancer; 1974 Jul; 14(1):65-82. PubMed ID: 4376509
    [No Abstract]   [Full Text] [Related]  

  • 28. Regulation of the immune response. VIII. Characteristics of antibody-mediated suppression of an in vitro cell-mediated immune response.
    Sinclair NR; Lees RK; Fagan G; Birnbaum A
    Cell Immunol; 1975 Apr; 16(2):330-47. PubMed ID: 803878
    [No Abstract]   [Full Text] [Related]  

  • 29. Cell-mediated immune response in vitro. II. The role of thymus and thymus-derived lymphocytes.
    Wagner H; Harris AW; Feldmann M
    Cell Immunol; 1972 May; 4(1):39-50. PubMed ID: 4401545
    [No Abstract]   [Full Text] [Related]  

  • 30. Cytotoxicity of isolated plasma membranes from lymph node cells.
    Ferluga J; Allison AC
    Nature; 1975 Jun; 255(5511):708-10. PubMed ID: 806024
    [No Abstract]   [Full Text] [Related]  

  • 31. Mechanisms of lymphocyte-mediated cytotoxicity. II. biochemical and serologic identification of a precursor lymphotoxin form (pre-LT) produced by MLC-sensitized human T lymphocytes in vitro.
    Ware CF; Harris PC; Granger GA
    J Immunol; 1981 May; 126(5):1927-33. PubMed ID: 6163823
    [No Abstract]   [Full Text] [Related]  

  • 32. Inhibition of cell-mediated cytotoxicity in the rat by anti-thymocyte serum.
    Sanderson CJ; Franks D
    Immunology; 1974 Dec; 27(6):1045-51. PubMed ID: 4375670
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Studies on lymphokines: the production of antibody to guinea pig lymphotoxin and its use to distinguish lymphotoxin from migration inhibitory factor and mitogenic factor.
    Gately MK; Gately CL; Henney CS; Mayer MM
    J Immunol; 1975 Sep; 115(3):817-26. PubMed ID: 1097529
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Morphological observations on the contact-induced lysis of target cells.
    Koren HS; Ax W; Freund-Moelbert E
    Eur J Immunol; 1973 Jan; 3(1):32-7. PubMed ID: 4197969
    [No Abstract]   [Full Text] [Related]  

  • 35. The mechanism of K cell (antibody-dependent) cell mediated cytotoxicity. II. Characteristics of the effector cell and morphological changes in the target cell.
    Sanderson CJ; Thomas JA
    Proc R Soc Lond B Biol Sci; 1977 Jul; 197(1129):417-24. PubMed ID: 18739
    [No Abstract]   [Full Text] [Related]  

  • 36. The genetic control of T cell-meditated immunity. I. Characterization of a mouse strain whose low responsiveness is inherited as a recessive trait.
    Vachek H; Kölsch E
    Immunology; 1974 Oct; 27(4):507-15. PubMed ID: 4215740
    [TBL] [Abstract][Full Text] [Related]  

  • 37. T-lymphocyte mediated lysis of tumor cells in the presence of alloantiserum.
    Liepins A; Faanes RB; Choi YS; de Harven E
    Cell Immunol; 1978 Mar; 36(2):331-44. PubMed ID: 415815
    [No Abstract]   [Full Text] [Related]  

  • 38. The cytolytic activity of human lymphocytes. I. Cytolytic activity towards PPD-coated target cells in tuberculin positive and negative individuals.
    Rehn TG; Henney CS
    Johns Hopkins Med J; 1972 Oct; 131(4):261-70. PubMed ID: 5081728
    [No Abstract]   [Full Text] [Related]  

  • 39. Stimulator T cells: involvement in the induction of cell-mediated cytotoxicity.
    Dennert G
    J Immunol; 1975 May; 114(5):1570-3. PubMed ID: 804519
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Specific killing of line-10 cells in vitro in the presence of normal lymphoid cells and antibodies from immune rabbits or tumor-resistant guinea pigs.
    Brunda MJ; Minden P; Ferguson HR
    J Immunol; 1978 Nov; 121(5):1927-32. PubMed ID: 712071
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.